UAE investment drives Middle East biopharma transformation as precision medicine set for double-digit growth

Exclusive analysis for World Health Expo (WHX) by Frost & Sullivan forecasts precision medicine growth of more than 10% in the Middle East over the next five to seven years Emirati Genome Program, Abu …